Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections

PD Tamma, EL Heil, JA Justo… - Clinical infectious …, 2024 - academic.oup.com
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections …

It's Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa

P Behzadi, Z Baráth, M Gajdács - Antibiotics, 2021 - mdpi.com
Pseudomonas aeruginosa is the most frequent cause of infection among non-fermenting
Gram-negative bacteria, predominantly affecting immunocompromised patients, but its …

Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem …

PD Tamma, SL Aitken, RA Bonomo… - Clinical Infectious …, 2022 - academic.oup.com
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …

Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program …

D Shortridge, AC Gales, JM Streit… - Open forum …, 2019 - academic.oup.com
Abstract Background The SENTRY Antimicrobial Surveillance Program was established in
1997 and encompasses over 750 000 bacterial isolates from≥ 400 medical centers …

[HTML][HTML] Insertional inactivation of oprD in carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, Iran

A Shariati, T Azimi, A Ardebili, AS Chirani… - New microbes and new …, 2018 - Elsevier
In this study, we report the insertion sequence ISPpu21 in the oprD porin gene of
carbapenem-resistant Pseudomonas aeruginosa isolates from burn patients in Tehran, Iran …

Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam

AM Hujer, SH Marshall, AR Mack, KM Hujer… - MBio, 2023 - Am Soc Microbiol
Multi-drug resistant (MDR) Pseudomonas aeruginosa harbor a complex array of β-
lactamases and non-enzymatic resistance mechanisms. In this study, the activity of a β …

The experience of implementing a national antimicrobial resistance surveillance system in Brazil

M Pillonetto, RTS Jordão, GS Andraus… - Frontiers in Public …, 2021 - frontiersin.org
Antimicrobial resistance (AMR) is a major public health threat of global proportions, which
has the potential to lead to approximately ten million deaths per year by 2050. Pressured by …

A Critical Evaluation of Newer β-Lactam Antibiotics for Treatment of Pseudomonas aeruginosa Infections

KC Blomquist, DE Nix - Annals of Pharmacotherapy, 2021 - journals.sagepub.com
Objective: This article critically evaluates common Pseudomonas aeruginosa resistance
mechanisms and the properties newer β-lactam antimicrobials possess to evade these …

Characterization of carbapenem-resistant but cephalosporin-susceptible Pseudomonas aeruginosa

Y Khalili, M Yekani, HR Goli… - Acta microbiologica et …, 2019 - akjournals.com
In this study, mechanisms of carbapenem resistance in carbapenem-resistant but
cephalosporin-susceptible (Car-R/Ceph-S) Pseudomonas aeruginosa were investigated. A …

In vitro and in vivo antibacterial activity assays of carvacrol: A candidate for development of innovative treatments against KPC-producing Klebsiella pneumoniae

GHA de Souza, JA dos Santos Radai, MS Mattos Vaz… - PloS one, 2021 - journals.plos.org
Dissemination of carbapenem-resistant Klebsiella pneumoniae poses a threat to the
successful treatment of bacterial diseases and increases the need for new antibacterial …